Enzyvant Therapeutics Ireland Limited was set up on Wednesday the 10th of October 2018. Their current partial address is Dublin 2, and the company status is Dissolved with the company closing on Friday the 25th of April 2025. The company's current director has been the director of 5 other Irish companies. Enzyvant Therapeutics Ireland Limited has 1 shareholder. This Irish company shares its Eircode with at least 214 other companies.
| Company Name: | Enzyvant Therapeutics Ireland Limited | |
| Company Status: | DISSOLVED | |
| RiskWatch | Form E2: Notice of Appointment of Liquidator(s) Effective Date 07/06/2024 | |
| Company Address: | Riverside Two, Sir John Rogerson's Quay, Dublin 2, , Ireland | |
| Key Executive: | Mr Kiernan | |
| Company Size: | Log-In To View | |
| Established: | 10/10/2018 (7 years in business). | |
Mr Kiernan is a Company Director of Enzyvant Therapeutics Ireland Limited since 2018 and a listed Director of 2 other companies.
Generate a B2B Marketing List with ease and grow your business. Identify key decision makers and pre-qualified new prospects for your sales and business development teams.
Similar Companies - Create a marketing list of similar companies
The latest documents filed with the Companies Registration Office for Enzyvant Therapeutics Ireland Limited (which can include the Account Details) are listed below.
| CRO Document | Effective Date | Received By CRO | View Now | |
|---|---|---|---|---|
| Form G1 - Special Resolution to Wind up | 19/12/2024 | 20/12/2024 | Join Up | |
| Form E6: Return of final winding up meeting | 19/12/2024 | 20/12/2024 | Join Up | |
| Form E5: Liquidator`s Final Statement of Accounts | 19/12/2024 | 20/12/2024 | Join Up | |
| Form B2: Change of Company Registered Office Address | 07/06/2024 | 31/07/2024 | Join Up | |
| Form E2: Notice of Appointment of Liquidator(s) | 07/06/2024 | 26/06/2024 | Join Up | |
| THIS COMPANY HAS 25 OTHER DOCS » | ||||
View CRO company documents and company reports any Irish company or business with ease.
View the Latest Credit Report and Credit Limit on Enzyvant Therapeutics Ireland Limited.
| Company Status: | Dissolved | |
| RiskWatch | Form E2: Notice of Appointment of Liquidator(s) Effective Date 07/06/2024 | |
| Latest Credit Movement: |  | |
| Date of Last Movement: | 15/03/2025 | |
| Latest Accounts Filed: | 04/12/2023 | |
| Report Based on Accounts: | 31/03/2023 | |
| Next Set of Accounts Due: | 10/10/2024 | |
| Overdue: | Yes | |
| Credit Score: | Join-Up to View | |
To View the latest Credit Rating or Credit Limit on Enzyvant Therapeutics Ireland Limited simply click 'Log-In' or 'Join-Up' below.
Vision-net Credit Scores save your business the time and cost of chasing slow payers. Evaluate risk at client application stage or run continuous credit checks on your full customer base.
Satisfy due diligence requirements on Enzyvant Therapeutics Ireland Limited in one single 'time-saving' search. Run full background checks for Fitness and Probity on the directors of Enzyvant Therapeutics Ireland Limited and Anti-Money Laundering checks (AML checks) on Enzyvant Therapeutics Ireland Limited
| Company Type: | LTD - Private Company Limited By Shares |
| Number of Shareholders: | 1 |
Log-in now to run Due Diligence checks and Compliance checks on Enzyvant Therapeutics Ireland Limited or click Join-up to get started.
Background check Companies, Sole Traders or Individuals and minimise your spend with more efficient Anti-Money Laundering checks and reports.
More people choose Vision-net over any other search service... ask us why?
05/05/2025
At CRIFVision-net, we recognise the growing importance of ESG indicators in today's business landscape, whether it?s for reputational reasons or part of your sustainability strategy.
29/04/2025
In line with the latest Corporate Sustainability Reporting Directive (CSRD) requirements, CRIFVision-net now provides ESG scores on every Irish company.
21/04/2025
In today's unpredictable economy, making informed business decisions while reducing risk can be challenging.
14/04/2025
Our latest figures outline a promising start to 2025 for Irish entrepreneurs.
